SPOTLIGHT: L'Oreal selling off chunk of Sanofi stock
L'Oreal is cutting its stake in Sanofi-Aventis by 1.8 percent by selling off shares through sales to institutional investors; the company will retain am 8.7 percent share in the drug maker. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.